- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 17th, 2007
Tempo Hurries To Target Nanoparticle Combo Drugs
Tempo Pharmaceuticals Inc. isn't wasting any time. Since its founding in late 2006, the Cambridge, Mass.-based company has raised Seed and Series A financings, licensed core technology, hired 15 employees, started partnership discussions and begun the process of translating its platform into a product fit for clinical trials.
Yet founder and CEO Alan Crane said the name Tempo refers not to the company's frenetic pace, but to the "temporal release" of multiple drugs from its Nanocell platform technology.
|Related News Press|
Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015
A new technique to make drugs more soluble August 28th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Seeing quantum motion August 30th, 2015
Draw out of the predicted interatomic force August 30th, 2015